Position in TIL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,964,664
-$355,080 QoQ
Shares Held
645,600
0.0% QoQ
Ownership
9.52%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#2
of 26 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BML Capital Management, LLC holds $130,180,167 across 10 Biotechnology names. TIL ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
|
11,975,000 | $63,347,750 | |
| 2 | AVIR |
Atea Pharmaceuticals, Inc.
|
6,952,330 | $32,328,334 | |
| 3 | ENGN |
enGene Therapeutics Inc.
|
6,669,908 | $11,538,940 | |
| 4 | PMVP |
PMV Pharmaceuticals, Inc.
|
5,330,000 | $7,142,200 | |
| 5 | TIL |
Instil Bio, Inc.
This page
|
645,600 | $4,964,664 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
866,269 | $4,166,753 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
154,961 | $2,380,200 | |
| 8 | PLRX |
Pliant Therapeutics, Inc.
|
1,546,137 | $1,762,596 |
All Filings in TIL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,964,664 | 645,600 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,319,744 | 645,600 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,101,600 | 645,600 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $11,530,416 | 645,600 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,141,946 | 534,899 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $7,234,259 | 416,720 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,636,000 | 400,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $22,552,200 | 335,000 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,024,449 | 391,103 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,766,338 | 348,735 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||